Sunday, October 21, 2018
- 9:00AM-11:00AM
-
Abstract Number: 657
First Validation of Consensus Definitions for MRI Lesions in the Sacroiliac Joint By the Assessments in Spondyloarthritis International Society MRI Group
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Imaging, Clinical Studies, and Treatment- 9:00AM-11:00AM
-
Abstract Number: 686
Five-Year Efficacy and Safety of Apremilast Treatment in Subjects with Psa: A Pooled Analysis of the 3 Phase III Studies
Spondyloarthritis Including Psoriatic Arthritis – Clinical Poster I: Imaging, Clinical Studies, and Treatment- 9:00AM-11:00AM
-
Abstract Number: 171
Flow Cytometric Assessment of the Mammalian Target of Rapamycin Pathway Using Antiphospholipid Syndrome As a Disease Model
Antiphospholipid Syndrome Poster- 9:00AM-11:00AM
-
Abstract Number: 795
Frequency and Clinical Associations of Rare Antibodies in a Large Connective Tissue Disease Cohort
Systemic Sclerosis and Related Disorders – Clinical Poster I- 9:00AM-11:00AM
-
Abstract Number: 270
Gaps in Knowledge about the Ontario Trillium Drug Program
Healthcare Disparities in Rheumatology Poster- 9:00AM-11:00AM
-
Abstract Number: 790
Gastrointestinal Symptom Burden and Quality of Life in Systemic Sclerosis: Understanding the Role of Diet
Systemic Sclerosis and Related Disorders – Clinical Poster I- 9:00AM-11:00AM
-
Abstract Number: 133
GBR830, a True OX40 Antagonist Antibody with Potent Suppressive Effects on T Cell-Mediated Pathological Responses
T Cell Biology and Targets in Autoimmune and Inflammatory Disease Poster- 9:00AM-11:00AM
-
Abstract Number: 276
Gender Differences in TNFi Treatment Adherence and Response in As Patients: A Prospective Longitudinal Cohort Study
Healthcare Disparities in Rheumatology Poster- 9:00AM-11:00AM
-
Abstract Number: 51
Genetic Ablation of Inducible Nitric Oxide Synthase in TNF Transgenic Mice with Inflammatory-Erosive Arthritis Prevents Lymph Node Expansion and Decreases Synovial Infiltrates
Rheumatoid Arthritis – Animal Models Poster- 9:00AM-11:00AM
-
Abstract Number: 565
Genetic Polymorphism in Dihydrofolate Reductase Impacts Methotrexate Polyglutamation in Adult Rheumatoid Arthritis
Rheumatoid Arthritis – Treatments Poster I: Strategy and Epidemiology- 9:00AM-11:00AM
-
Abstract Number: 100
Glycosphingolipids and Proteins in Urine Exosomes: Potential Biomarkers of Lupus Nephritis
Systemic Lupus Erythematosus – Etiology and Pathogenesis Poster I- 9:00AM-11:00AM
-
Abstract Number: 608
Half Dose Reduction of Methotrexate in Patient with RA Who Achieved Clinical Remission
Rheumatoid Arthritis – Treatments Poster I: Strategy and Epidemiology- 9:00AM-11:00AM
-
Abstract Number: 271
Health Care Disparities for Infectious and Non-Infectious Uveitis in the US
Healthcare Disparities in Rheumatology Poster- 9:00AM-11:00AM
-
Abstract Number: 275
Health Equity: Access to Rituximab for Patients Comparing Variable Access in a Single Rheumatology Clinic
Healthcare Disparities in Rheumatology Poster- 9:00AM-11:00AM
-
Abstract Number: 496
Heart Failure Risk Among Patients with Rheumatoid Arthritis: Association with Anti-Rheumatic Drugs